Oral Micronized Progesterone Cost in Indiana (2026)

What Does Oral Micronized Progesterone Actually Cost in Indiana?

The price you pay depends entirely on how you source it. Brand-name Prometrium, manufactured by AbbVie (originally Solvay), carries a manufacturer list price of $180 per month for a 30-capsule supply of 100 mg or 200 mg capsules. Almost nobody pays that number. Generic micronized progesterone, approved by the FDA and therapeutically equivalent to Prometrium, averages $45 per month at Indiana retail chains like CVS, Walgreens, and Kroger pharmacies 1.

Compounded progesterone from a licensed 503A pharmacy brings the cost down to roughly $25 per month, though availability varies by city. Indianapolis, Fort Wayne, and Evansville each have multiple compounding pharmacies that stock micronized progesterone capsules.

Three pricing tiers exist for Indiana patients in 2026:

| Source | Approximate Monthly Cost | |---|---| | Brand Prometrium (no insurance) | $180 | | Generic OMP (cash pay, retail) | $45 | | Compounded OMP (503A pharmacy) | $25 |

These figures reflect cash-pay pricing. Insurance copays, discount programs, and manufacturer coupons can shift the number in either direction.

How to Get the Lowest Price on Progesterone in Indiana

Start with a generic prescription. Every major Indiana retail pharmacy stocks FDA-approved generic micronized progesterone, and Indiana law permits automatic generic substitution unless the prescriber writes "dispense as written" 1. Ask your prescriber to write for "progesterone, micronized" rather than "Prometrium" to avoid any substitution barriers.

Discount cards from GoodRx, RxSaver, and SingleCare frequently cut the generic price below $30 at select Indiana pharmacies. Prices shift weekly, so checking two or three platforms before filling is worth the 90 seconds it takes. The AbbVie savings card for Prometrium may reduce brand copays for commercially insured patients, but it does not apply to government programs like Medicaid or Medicare Part D.

Compounding offers the deepest discount. Indiana permits 503A compounding pharmacies to prepare micronized progesterone capsules under a patient-specific prescription. A 30-day supply of 200 mg capsules typically costs $20 to $30, depending on the pharmacy. Compounded formulations are not FDA-approved as finished products, but the active ingredient is the same USP-grade micronized progesterone used in Prometrium 2.

Does Indiana Medicaid Cover Oral Micronized Progesterone?

No, not for hormone replacement therapy. Indiana Medicaid covers oral micronized progesterone only for type 2 diabetes-related indications, not for endometrial protection in postmenopausal women on estrogen therapy. This creates a coverage gap for Medicaid-enrolled patients who need progesterone as part of an HRT regimen.

Patients on Indiana Medicaid who require endometrial protection have a few options. The first is to appeal with clinical documentation. The PEPI Trial (N=875) demonstrated that oral micronized progesterone provided endometrial protection equivalent to medroxyprogesterone acetate (MPA) while producing a more favorable lipid profile 2. A prior authorization request citing PEPI data and the 2022 Endocrine Society clinical practice guidelines may succeed, though approval is not guaranteed 3.

The second option is to use a compounded formulation at $25 per month out of pocket. For patients on a fixed income, this may be the most practical path.

Dr. JoAnn V. Pinkerton, past president of the North American Menopause Society, has stated: "Micronized progesterone is the preferred progestogen for most women on hormone therapy due to its neutral metabolic profile and lower breast cancer signal compared to synthetic progestins" 4.

Which Commercial Insurance Plans Cover OMP in Indiana?

Most major commercial insurers in Indiana place generic micronized progesterone on a Tier 1 or Tier 2 formulary. Anthem Blue Cross Blue Shield (the dominant carrier in the state), UnitedHealthcare, Cigna, and Aetna all cover generic OMP with copays typically ranging from $5 to $20 per month for a 30-day supply.

Brand Prometrium usually sits on Tier 3, requiring a higher copay of $35 to $75 and sometimes a prior authorization if the insurer prefers generic substitution first. Marketplace plans purchased through the federal exchange (healthcare.gov) in Indiana follow similar formulary tiers.

Medicare Part D plans cover generic micronized progesterone, but cost-sharing varies by plan. The 2022 Endocrine Society guidelines recommend micronized progesterone over synthetic progestins for most postmenopausal women, which strengthens coverage arguments when prior authorization is required 3.

Patients with high-deductible health plans (HDHPs) may pay the full cash price until their deductible is met. In that case, the generic cash price of $45 (or a discount card price below $30) is often cheaper than applying the purchase toward a $3,000 deductible.

Is Compounded Progesterone Legal in Indiana?

Yes. Indiana permits licensed 503A compounding pharmacies to prepare patient-specific prescriptions for micronized progesterone. These pharmacies operate under Indiana Board of Pharmacy oversight and must comply with USP 795 and USP 797 standards for non-sterile and sterile compounding, respectively.

The distinction matters. A 503A pharmacy compounds medications for individual patients based on a specific prescription. A 503B outsourcing facility, registered with the FDA, can prepare larger batches without patient-specific prescriptions. Both pathways are legal in Indiana.

Compounded progesterone capsules use USP-grade micronized progesterone powder suspended in a carrier (often olive oil rather than the peanut oil used in Prometrium). This is relevant for patients with peanut allergies. The PEPI Trial used the same USP-grade micronized progesterone that compounding pharmacies stock today 2.

One caveat: compounded medications do not undergo the same FDA finished-product review as brand or generic drugs. The Endocrine Society's 2020 scientific statement on compounded bioidentical hormones noted that "compounded hormones carry risks related to variable potency, purity, and lack of efficacy data from controlled trials" 5. Patients choosing compounded progesterone should verify that their pharmacy holds current state licensure and follows USP standards.

Can You Get Oral Micronized Progesterone via Telehealth in Indiana?

Indiana allows telehealth prescribing of oral micronized progesterone with no in-person visit requirement for the initial prescription. This policy, solidified after pandemic-era regulatory changes, means patients in rural Indiana counties without nearby OB-GYN or endocrinology offices can access OMP through a video consultation.

HealthRX and other telehealth platforms licensed in Indiana can prescribe OMP and ship it to the patient's address or send the prescription electronically to a local pharmacy. Telehealth visits typically cost $50 to $150 without insurance, and many commercial plans now cover telehealth at parity with in-person visits.

The practical benefit is significant. Thirty-one of Indiana's 92 counties are classified as medically underserved areas by HRSA 6. For a patient in Perry County or Switzerland County, a telehealth visit eliminates a 90-minute drive to the nearest prescribing clinician.

Clinical Background: Why Micronized Progesterone Over Synthetic Progestins?

The PEPI Trial (Postmenopausal Estrogen/Progestin Interventions), published in JAMA in 1995, enrolled 875 postmenopausal women and compared four HRT regimens against placebo over three years. Women randomized to conjugated equine estrogens plus oral micronized progesterone (200 mg, cyclic 12 days per month) experienced endometrial protection equivalent to the MPA arm, with significantly better HDL cholesterol preservation. Mean HDL increased 4.1 mg/dL with OMP versus a 2.4 mg/dL decrease with MPA 2.

The cardiovascular signal matters. A 2019 meta-analysis in the European Journal of Preventive Cardiology (N=38,908 across 19 studies) found that micronized progesterone was associated with a lower risk of venous thromboembolism compared to synthetic progestins (OR 0.93 to 95% CI 0.65 to 1.33 for OMP vs. OR 1.54 for MPA) 7.

The E3N cohort study, a French prospective study of 80,377 postmenopausal women followed for a mean of 8.1 years, reported that estrogen combined with micronized progesterone did not significantly increase breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22), while estrogen plus synthetic progestins carried a relative risk of 1.69 8.

Dr. Avrum Bluming, oncologist and co-author of "Estrogen Matters," has noted: "The data consistently show that micronized progesterone carries a different risk profile than medroxyprogesterone acetate, and clinicians should not treat all progestogens as interchangeable" 8.

Dosing and How to Take OMP

The FDA-approved labeling for Prometrium specifies two regimens for endometrial protection 1:

• Cyclic dosing: 200 mg nightly for 12 consecutive days per 28-day cycle (paired with continuous estrogen)
• Continuous dosing: 100 mg nightly every day (paired with continuous estrogen)

Take OMP at bedtime. The capsule produces a metabolite, allopregnanolone, that has GABA-A receptor agonist activity and causes drowsiness. This side effect doubles as a benefit for women with menopause-related insomnia. A 2018 study in Menopause (N=186) found that bedtime OMP improved subjective sleep quality scores by 32% compared to placebo over 12 weeks 9.

Take the capsule with food. The FDA labeling notes that food increases bioavailability of micronized progesterone by approximately 25% 1.

Patients with peanut allergies should not use brand Prometrium, which contains peanut oil as an excipient. Generic versions and compounded formulations may use alternative carriers like olive oil or sesame oil. Confirm the inactive ingredients with your pharmacist before filling.

What to Know Before Filling Your Prescription in Indiana

Three steps can save Indiana patients $100 or more per month on oral micronized progesterone.

First, request generic micronized progesterone by name. The average savings over brand Prometrium: $135 per month.

Second, compare prices across at least three pharmacies using a discount card platform. Indiana pharmacy pricing varies by as much as 40% between chains in the same zip code.

Third, ask your prescriber whether a compounded formulation is appropriate for your situation. If you have no peanut allergy concerns and your prescriber is comfortable with a 503A pharmacy, the $25 per month compounded option is the lowest-cost path available in Indiana.

For patients whose insurance denies coverage, a letter of medical necessity citing the PEPI Trial data 2 and the Endocrine Society 2022 guidelines 3 gives the strongest foundation for a prior authorization appeal. Include the specific ICD-10 code (N95.1 for menopausal and postmenopausal states) and document the clinical rationale for OMP over synthetic alternatives.